Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Alcoholic Dehydrogenase (ALDH) Enzyme Supplement in Chemotherapy-Related Fatigue With Advanced Gastrointestinal Cancer Patients: A 2-Period, Crossover, Single-Center Study

NCT05030363 is registered in ClinicalTrials.gov with Korea University Anam Hospital as lead sponsor.

NCT NCT05030363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05030363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Alcoholic Dehydrogenase (ALDH) Enzyme Supplement in Chemotherapy-Related Fatigue With Advanced Gastrointestinal Cancer Patients: A 2-Period, Crossover, Single-Center Study
Lead sponsor
Korea University Anam Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
October 25, 2021
Completion date
December 31, 2022
Enrollment
82 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aldehyde dehydrogenase, fatigue, gastrointestinal cancer